Q

Qingdao Baheal Medical Inc
SZSE:301015

Watchlist Manager
Qingdao Baheal Medical Inc
SZSE:301015
Watchlist
Price: 27.18 CNY -1.52% Market Closed
Market Cap: 14.3B CNY
Have any thoughts about
Qingdao Baheal Medical Inc?
Write Note
Section:
 

Relative Value

The Relative Value of one Qingdao Baheal Medical Inc stock under the Base Case scenario is 50.46 CNY. Compared to the current market price of 27.18 CNY, Qingdao Baheal Medical Inc is Undervalued by 46%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
50.46 CNY
Undervaluation 46%
Relative Value
Price
Q
Worst Case
Base Case
Best Case

Valuation Multiples

1.9
P/S
P/S
Price to Sales
1.9
vs History
37
vs Industry
55
Median 3Y
1.9
Median 5Y
1.9
Industry
2.4
Forward
1.7
More Details
19.8
P/E
P/E
Price to Earnings
19.8
vs History
81
vs Industry
31
Median 3Y
25.6
Median 5Y
26.2
Industry
23.5
Forward
17.1
More Details
21.6
P/OCF
P/OCF
Price to OCF
21.6
vs History
86
vs Industry
19
Median 3Y
29.6
Median 5Y
30.3
Industry
14.7
More Details
16.2
P/FCFE
P/FCFE
Price to FCFE
16.2
vs History
60
vs Industry
7
Median 3Y
32.6
Median 5Y
33.5
Industry
20.7
More Details
5.4
P/B
P/B
Price to Book Value
5.4
vs History
62
vs Industry
19
Median 3Y
5.8
Median 5Y
5.9
Industry
2.2
More Details
2
EV/S
EV/S
Enterprise Value to Sales
2
vs History
32
vs Industry
54
Median 3Y
1.9
Median 5Y
1.9
Industry
2.5
Forward
1.8
More Details
6.6
EV/GP
EV/GP
Enterprise Value to Gross Profit
6.6
vs History
58
vs Industry
39
Median 3Y
7
Median 5Y
7
Industry
5.1
More Details
15.5
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
15.5
vs History
79
vs Industry
26
Median 3Y
19.3
Median 5Y
19.4
Industry
12.9
Forward
12
More Details
15.5
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
15.5
vs History
79
vs Industry
32
Median 3Y
19.3
Median 5Y
19.4
Industry
17.6
Forward
13.1
More Details
22.8
EV/OCF
EV/OCF
Enterprise Value to OCF
22.8
vs History
86
vs Industry
19
Median 3Y
31.3
Median 5Y
31.5
Industry
14.5
More Details
28.6
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
28.6
vs History
81
vs Industry
17
Median 3Y
40.4
Median 5Y
40.5
Industry
18.8
More Details
4
EV/IC
EV/IC
Enterprise Value to IC
4
vs History
62
vs Industry
24
Median 3Y
4.3
Median 5Y
4.4
Industry
1.9
More Details

Multiples Across Competitors

Competitors Multiples
Qingdao Baheal Medical Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Qingdao Baheal Medical Inc
SZSE:301015
14.3B CNY 1.9 19.8 15.5 15.5
US
Mckesson Corp
NYSE:MCK
77.5B USD 0.2 30.6 18.3 21.4
US
Amerisourcebergen Corp
LSE:0HF3
48.9B USD 0.2 32.4 11.9 16.3
US
Cencora Inc
NYSE:COR
48.7B USD 0.2 32.2 11.9 16.3
US
Cardinal Health Inc
NYSE:CAH
30.4B USD 0.1 24 10.8 14.3
US
Henry Schein Inc
NASDAQ:HSIC
9.3B USD 0.7 29.7 13.1 19.3
CN
Huadong Medicine Co Ltd
SZSE:000963
65B CNY 1.6 20.2 15.4 15.4
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW 5.9 89.6 59.9 61.9
CN
Sinopharm Group Co Ltd
HKEX:1099
65.4B HKD 0.1 7.1 1.8 2.2
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
60.9B CNY 0.2 15.1 9.6 9.6
IT
Amplifon SpA
MIL:AMP
5.5B EUR 2.3 35 11.2 23.4

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 204,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.